Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HTGF is Germany's largest and most active early-stage investor. Since 2005, it has backed approximately 790 companies with €892.5 million across multiple seed funds. External investors have subsequently injected over €4.5 billion into HTGF's portfolio through more than 2,000 follow-on financing rounds.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on High-Tech Gründerfonds III.